These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 23228382

  • 21. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS, Hruska KA, Chandhoke PS.
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [Abstract] [Full Text] [Related]

  • 22. Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin.
    How PP, Fischer JH, Arruda JA, Lau AH.
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1235-40. PubMed ID: 17913970
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [Abstract] [Full Text] [Related]

  • 27. Role of cecal pH in intestinal oxalate absorption in the rat.
    Diamond KL, Fox CC, Barch DH.
    J Lab Clin Med; 1988 Sep; 112(3):352-6. PubMed ID: 3411198
    [Abstract] [Full Text] [Related]

  • 28. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR, Chen D, MacLennan GT, Resnick MI, Jacobs GH.
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Lanthanum carbonate and new phosphate binders in patients with chronic kidney disease].
    Negi S, Shigematsu T.
    Clin Calcium; 2010 Jul; 20(7):1096-102. PubMed ID: 20585189
    [Abstract] [Full Text] [Related]

  • 33. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C.
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [Abstract] [Full Text] [Related]

  • 34. Systemic lanthanum is excreted in the bile of rats.
    Damment SJ, Pennick M.
    Toxicol Lett; 2007 Jun 15; 171(1-2):69-77. PubMed ID: 17570622
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Absorption of glyoxylate and oxalate in thiamine and pyridoxine deficient rat intestine.
    Sidhu H, Gupta R, Farooqui S, Thind SK, Nath R.
    Biochem Int; 1986 Jan 15; 12(1):71-9. PubMed ID: 3947375
    [Abstract] [Full Text] [Related]

  • 37. The effect of oral administration of calcium and magnesium on intestinal oxalate absorption in humans.
    Voss S, Zimmermann DJ, Hesse A, von Unruh GE.
    Isotopes Environ Health Stud; 2004 Sep 15; 40(3):199-205. PubMed ID: 15370283
    [Abstract] [Full Text] [Related]

  • 38. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads.
    Liebman M, Costa G.
    J Urol; 2000 May 15; 163(5):1565-9. PubMed ID: 10751889
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.